Synhale has acquired telaglenastat, and is planning a Phase 2 clinical trial testing the therapy in patients with pulmonary ...

There are night owls and morning larks, writes columnist Colleen Steele, referring to people's sleep habits. So which bird are you?

A pivotal study testing Sensydia's noninvasive device, which may help diagnose pulmonary hypertension, enrolled its first ...

Cereno Scientific reported a successful meeting with the FDA on the design of a future clinical trial for its PAH therapy ...